Tucker Asset Management’s Alaunos Therapeutics TCRT Stock Holding History

Tucker Asset Management’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$3	Buy	+1	New	+$3	﹤0.01%	1077
2025 Q1	–	Sell	-1	Closed	-$2	–	855
2024 Q4	$2	Hold	1	–	–	﹤0.01%	1539
2024 Q3	$3	Hold	1	–	–	﹤0.01%	1452
2024 Q2	$9	Hold	1	–	–	﹤0.01%	1650
2024 Q1	$24	Hold	1	–	–	﹤0.01%	1614
2023 Q4	$14	Hold	1	–	–	﹤0.01%	1447
2023 Q3	$26	Hold	1	–	–	﹤0.01%	1355
2023 Q2	$102	Hold	1	–	–	﹤0.01%	1108
2023 Q1	$126	Hold	1	–	–	﹤0.01%	1116
2022 Q4	$131	Hold	1	–	–	﹤0.01%	775
2022 Q3	$230	Buy	+1	New	+$290	﹤0.01%	793

Other funds holding TCRT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Tucker Asset Management's TCRT Position: Q4 2025 in Review

Tucker Asset Management opened a new position in Alaunos Therapeutics (TCRT) in Q4 2025: 1 share worth $3. The stake represents ﹤0.01% of the portfolio and ranks #1077 among its holdings. This is a return to the name: Tucker Asset Management previously reported a position in TCRT as recently as Q4 2024.

Tucker Asset Management first reported a position in TCRT in Q3 2022 and has held it in 11 quarters since. The position peaked at $230 in Q3 2022. 27 funds tracked by Wall St. Rank hold TCRT as of Q4 2025.

Tucker Asset Management held 1 share of Alaunos Therapeutics worth $3 as of Q4 2025.
Alaunos Therapeutics was a new Tucker Asset Management position in Q4 2025.
Alaunos Therapeutics made up ﹤0.01% of Tucker Asset Management's portfolio in Q4 2025, its #1077 holding.
Tucker Asset Management first reported a position in Alaunos Therapeutics in Q3 2022 and has held it in 11 quarters since.
Tucker Asset Management's Alaunos Therapeutics position peaked at $230 in Q3 2022.
27 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2025.

Based on Tucker Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.